Medpace Holdings, Inc. (MEDP) income statement
MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3046% above fair value
$633.98−12.89 (-1.99%)
Close on Nov 19, 2026Market cap $17.73BP/E 35.2Yield –
Medpace Holdings, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- 21.4%
- Net margin
- 18.2%
- Return on equity, FY2025
- 70.2%
Financial strength
- Current ratio
- 0.83
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 47.1%
Valuation
- P/E ratio
- 35.2
- Price to sales
- 6.25
- Price to book
- 30.32
- Dividend yield
- –
See a number that looks wrong?